| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41598-017-10391-1 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41598-017-10391-1 |
| P932 | PMC publication ID | 5575021 |
| P698 | PubMed publication ID | 28852120 |
| P50 | author | Shunjie Bai | Q87134854 |
| P2093 | author name string | Wei Wang | |
| Yu Han | |||
| Jianjun Chen | |||
| Xiaodong Zhang | |||
| Peng Xie | |||
| Zhao Liu | |||
| Zhi Chen | |||
| Hua Huang | |||
| Li Zeng | |||
| Haiyang Wang | |||
| Peng Shen | |||
| Qingchuan Hu | |||
| Zihong Liang | |||
| Xiongfei Xie | |||
| Siwen Gui | |||
| P2860 | cites work | Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date | Q27004490 |
| The Extrinsic Coagulation Pathway: a Biomarker for Suicidal Behavior in Major Depressive Disorder | Q27349460 | ||
| Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis | Q28262885 | ||
| Sparse whole-genome sequencing identifies two loci for major depressive disorder | Q28265101 | ||
| Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress | Q29618764 | ||
| Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions | Q29620063 | ||
| Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy | Q30557070 | ||
| Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis | Q31127142 | ||
| Signaling pathways underlying the antidepressant-like effect of inosine in mice | Q33689441 | ||
| Role of the adipose PPARγ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors | Q33790412 | ||
| Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis | Q34530566 | ||
| Oral administration of inosine produces antidepressant-like effects in mice | Q34659961 | ||
| The CNS effects of Ginkgo biloba extracts and ginkgolide B. | Q34778214 | ||
| Cameroonian medicinal plants: pharmacology and derived natural products | Q35155222 | ||
| A standardized protocol for repeated social defeat stress in mice. | Q35561938 | ||
| 1H NMR-based metabolic profiling reveals the effects of fluoxetine on lipid and amino acid metabolism in astrocytes. | Q35585693 | ||
| Involvement of the catecholaminergic system on the antidepressant-like effects of Alpinia zerumbet in mice. | Q35606297 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| TagFinder for the quantitative analysis of gas chromatography--mass spectrometry (GC-MS)-based metabolite profiling experiments. | Q50657835 | ||
| Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. | Q50705251 | ||
| Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. | Q54139906 | ||
| Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. | Q55034361 | ||
| PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus | Q68699960 | ||
| Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion | Q73250494 | ||
| Antioxidative activity of natural products from plants | Q73461157 | ||
| Effect of various classes of antidepressants in behavioral paradigms of despair | Q80481523 | ||
| Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress. | Q36770623 | ||
| Circuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility | Q36978291 | ||
| The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects | Q37067679 | ||
| The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors. | Q37131954 | ||
| Insight into the metabolic mechanism of scoparone on biomarkers for inhibiting Yanghuang syndrome | Q37424787 | ||
| Frequency dependant topological alterations of intrinsic functional connectome in major depressive disorder. | Q37502040 | ||
| A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness | Q37752880 | ||
| Prefrontal cortex output circuits guide reward seeking through divergent cue encoding | Q38948174 | ||
| Transport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood-brain barrier cell model | Q38964414 | ||
| Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. | Q39017815 | ||
| Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles | Q39296220 | ||
| Targeted Metabolomic Pathway Analysis and Validation Revealed Glutamatergic Disorder in the Prefrontal Cortex among the Chronic Social Defeat Stress Mice Model of Depression | Q39418875 | ||
| Repeated social defeat causes increased anxiety-like behavior and alters splenocyte function in C57BL/6 and CD-1 mice | Q42114896 | ||
| Prefrontal cortex reactivity underlies trait vulnerability to chronic social defeat stress | Q42848805 | ||
| A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge | Q44186836 | ||
| Reduction of prefrontal cortex glucose metabolism common to three types of depression | Q45097380 | ||
| Omics Studies of the Murine Intestinal Ecosystem Exposed to Subchronic and Mild Social Defeat Stress | Q46507385 | ||
| Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress | Q46513792 | ||
| Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism | Q46565524 | ||
| Ginsenoside Rg1-induced antidepressant effects involve the protection of astrocyte gap junctions within the prefrontal cortex | Q47382247 | ||
| The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression | Q47444989 | ||
| GC-MS-based metabolomic study on the antidepressant-like effects of diterpene ginkgolides in mouse hippocampus | Q48046067 | ||
| Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression | Q48220933 | ||
| Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model | Q48236609 | ||
| Amino acid metabolic dysfunction revealed in the prefrontal cortex of a rat model of depression | Q48287388 | ||
| Dysfunctional glutamatergic and γ-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression | Q48399737 | ||
| Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors. | Q48469906 | ||
| Neurobiology of Chronic Social Defeat Stress: Role of Brain-Derived Neurotrophic Factor Signaling in the Nucleus Accumbens. | Q48549334 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9591 | |
| P577 | publication date | 2017-08-29 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine | |
| P478 | volume | 7 |
| Q104795022 | CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice |
| Q92059662 | Diterpene Ginkgolides Exert an Antidepressant Effect Through the NT3-TrkA and Ras-MAPK Pathways |
| Q89747520 | Dl-3-n-butylphthalide attenuates mouse behavioral deficits to chronic social defeat stress by regulating energy metabolism via AKT/CREB signaling pathway |
| Q90353598 | Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression |
| Q55714791 | Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex. |
| Q93185341 | Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus |
Search more.